Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Discovery and development of oral recombinant protein vaccines, based on its proprietary oral6.4M100.00%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States7.38M100.00%
